- Home
- BEAT vs DHAI Comparison
BEAT vs DHAI Comparison
Compare BEAT & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- DHAI
- Stock Information
- Founded
- BEAT 2015
- DHAI 2007
- Country
- BEAT United States
- DHAI United States
- Employees
- BEAT N/A
- DHAI N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- DHAI
- Sector
- BEAT Technology
- DHAI
- Exchange
- BEAT Nasdaq
- DHAI NYSE
- Market Cap
- BEAT 62.7M
- DHAI 55.5M
- IPO Year
- BEAT 2021
- DHAI N/A
- Fundamental
- Price
- BEAT $2.29
- DHAI $1.00
- Analyst Decision
- BEAT Buy
- DHAI
- Analyst Count
- BEAT 1
- DHAI 0
- Target Price
- BEAT $8.00
- DHAI N/A
- AVG Volume (30 Days)
- BEAT 96.6K
- DHAI 19.3K
- Earning Date
- BEAT 11-07-2024
- DHAI 11-14-2024
- Dividend Yield
- BEAT N/A
- DHAI N/A
- EPS Growth
- BEAT N/A
- DHAI N/A
- EPS
- BEAT N/A
- DHAI N/A
- Revenue
- BEAT N/A
- DHAI $72,410,000.00
- Revenue This Year
- BEAT N/A
- DHAI N/A
- Revenue Next Year
- BEAT N/A
- DHAI N/A
- P/E Ratio
- BEAT N/A
- DHAI N/A
- Revenue Growth
- BEAT N/A
- DHAI 13.28
- 52 Week Low
- BEAT $1.06
- DHAI $0.72
- 52 Week High
- BEAT $3.39
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- BEAT 47.26
- DHAI 26.15
- Support Level
- BEAT $2.33
- DHAI $0.84
- Resistance Level
- BEAT $2.61
- DHAI $1.40
- Average True Range (ATR)
- BEAT 0.19
- DHAI 0.12
- MACD
- BEAT -0.03
- DHAI -0.02
- Stochastic Oscillator
- BEAT 13.73
- DHAI 27.03
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.